1. Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer
   Lei Guo et al, 2017, Breast Cancer Research and Treatment CrossRef
2. STATISTICAL ANALYSIS OF 100 BREAST CANCER CASES WITH EVALUATION OF HER2/NEU STATUS IMMUNOHISTOCHEMISTRY CORRELATION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION ASSAY
   Sivakami Sivakami et al, 2018, Journal of Evolution of Medical and Dental Sciences CrossRef
3. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
   Sandra V Fernandez et al, 2014, Breast Cancer Research CrossRef